Search Results - "Elander, Nils O"

Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer by Blomstrand, Hakon, Scheibling, Ursula, Bratthäll, Charlotte, Green, Henrik, Elander, Nils O

“…In the recent phase III trial MPACT the combination of gemcitabine and nab-paclitaxel (Gem/NabP) showed increased overall survival compared to gemcitabine…”
Get full text

Activity and safety of KEES - an oral multi-drug chemo-hormonal metronomic combination regimen in metastatic castration-resistant prostate cancer by Asowed, Mustafa, Elander, Nils O, Pettersson, Linn, Ekholm, Maria, Papantoniou, Dimitrios

“…Metastatic castration-resistant prostate cancer (mCRPC) remains a therapeutic challenge and evidence for late-line treatments in real-life is limited. The…”
Get full text

Real-World Evidence on Palliative Gemcitabine and Oxaliplatin (GemOx) Combination Chemotherapy in Advanced Biliary Tract Cancer by Lagenfelt, Hanna, Blomstrand, Hakon, Elander, Nils O.

“…Background: Gemcitabine and oxaliplatin (GemOx) is a standard combination regimen in advanced biliary tract cancer (BTC). There is limited evidence on its…”
Get full text

Clinical characteristics and blood/serum bound prognostic biomarkers in advanced pancreatic cancer treated with gemcitabine and nab-paclitaxel by Blomstrand, Hakon, Green, Henrik, Fredrikson, Mats, Gränsmark, Emma, Björnsson, Bergthor, Elander, Nils O

“…In recent years treatment options for advanced pancreatic cancer have markedly improved, and a combination regimen of gemcitabine and nab-paclitaxel is now…”
Get full text

Real World Evidence on Second-Line Palliative Chemotherapy in Advanced Pancreatic Cancer by Gränsmark, Emma, Bågenholm Bylin, Nellie, Blomstrand, Hakon, Fredrikson, Mats, Åvall-Lundqvist, Elisabeth, Elander, Nils O.

“…Background: The outcome and tolerability of palliative second line chemotherapy for advanced pancreatic cancer (APC) in real life patients are largely unknown…”
Get full text

TRIM study protocol - a prospective randomized multicenter Trial to assess the Role of Imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant Melanoma by Naeser, Ylva, Helgadottir, Hildur, Brandberg, Yvonne, Hansson, Johan, Bagge, Roger Olofsson, Elander, Nils O, Ingvar, Christian, Isaksson, Karolin, Flygare, Petra, Nilsson, Cecilia, Jakobsson, Frida, Del Val Munoz, Olga, Valachis, Antonis, Jansson, Malin, Sparring, Charlotte, Ohlsson, Lars, Dyrke, Ulf, Papantoniou, Dimitrios, Sundin, Anders, Ullenhag, Gustav J

“…The incidence of cutaneous malignant melanoma (CMM) is increasing worldwide. In Sweden, over 4600 cases were diagnosed in 2018. The prognosis after radical…”
Get full text

Efficacy of mistletoe extract as a complement to standard treatment in advanced pancreatic cancer: study protocol for a multicentre, parallel group, double-blind, randomised, placebo-controlled clinical trial (MISTRAL) by Wode, Kathrin, Hök Nordberg, Johanna, Kienle, Gunver S, Elander, Nils O, Bernhardson, Britt-Marie, Sunde, Berit, Sharp, Lena, Henriksson, Roger, Fransson, Per

“…Most pancreatic cancer patients present with advanced stage at diagnosis with extremely short expected survival and few treatment options. A multimodal…”
Get full text

Mutation Analysis of the FGFR3-encoding gene Does Not Predict Response to Checkpoint Inhibitor Treatment in Metastatic Bladder Cancer by Elander, Nils O., Hussain, Syed A.

Get full text

Impact of resection margins and para-aortic lymph node metastases on recurrence patterns and prognosis in resectable pancreatic cancer – a long-term population-based cohort study by Blomstrand, Hakon, Olsson, Hans, Green, Henrik, Björnsson, Bergthor, Elander, Nils O.

“…Pancreatic cancer remains a leading cause of cancer-related death. To individualise management and improve survival, more accurate prognostic models are…”
Get full text

MRI Lymph Node Evaluation for Prediction of Metastases in Rectal Cancer by Almlöv, Karin, Woisetschläger, Mischa, Loftås, Per, Hallböök, Olof, Elander, Nils O, Sandström, Per

“…To explore whether the size and characteristics of the largest regional lymph node in patients with rectal cancer, based on magnetic resonance imaging (MRI),…”
Get full text

Assessment by a multidisciplinary team conference affects treatment strategy and overall survival in patients with synchronous colorectal liver metastases by Almlöv, Karin, Arbman, Gunnar, Björnsson, Bergthor, Elander, Nils O., Hager, Jakob, Hamid, Salik, Landerholm, Kalle, Loftås, Per, Sandström, Per

“…The aim of this retrospective observational study was to investigate the geographical or sex differences in patients with synchronous colorectal liver…”
Get full text

Real world aspects of palliative trifluridine plus tiperacil (TAS-102) in refractory metastatic colorectal cancer by Wallander, Mikael, Rolander, Bo, Åvall-Lundqvist, Elisabeth, Elander, Nils O

“…While recent randomised phase III trials show that trifluridine/tiperacil (TAS-102) may prolong life in patients with refractory metastatic colorectal cancer…”
Get full text

PARP Inhibition in Prostate Cancer: A Promising Approach by Elander, Nils O, Hussain, Syed A

Get more information

hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA by Aughton, Karen, Elander, Nils O, Evans, Anthony, Jackson, Richard, Campbell, Fiona, Costello, Eithne, Halloran, Christopher M, Mackey, John R, Scarfe, Andrew G, Valle, Juan W, Carter, Ross, Cunningham, David, Tebbutt, Niall C, Goldstein, David, Shannon, Jennifer, Glimelius, Bengt, Hackert, Thilo, Charnley, Richard M, Anthoney, Alan, Lerch, Markus M, Mayerle, Julia, Palmer, Daniel H, Büchler, Markus W, Ghaneh, Paula, Neoptolemos, John P, Greenhalf, William

“…Gemcitabine or 5-fluorouracil (5-FU) based treatments can be selected for pancreatic cancer. Equilibrative nucleoside transporter 1 (hENT1) predicts adjuvant…”
Get full text

VICTOR: Vinflunine in advanced metastatic transitional cell carcinoma of the urothelium: A retrospective analysis of the use of vinflunine in multi-centre real life setting as second line chemotherapy through Free of Charge Programme for patients in the UK and Ireland by Hussain, Syed A, Ansari, Jawaher, Huddart, Robert, Power, Derek G, Lyons, Jeanette, Wylie, James, Vilarino-Varlela, Maria, Elander, Nils O, McMenemin, Rhona, Pickering, Lisa M, Faust, Guy, Chauhan, Seema, Jackson, Richard J

“…There is no standard of care in the UK or Ireland for second-line chemotherapy for patients with advanced transitional cell carcinoma (TCCU). Vinflunine is…”
Get full text

Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study) by Naeser, Ylva, Helgadottir, Hildur, Hansson, Johan, Ingvar, Christian, Elander, Nils O, Flygare, Petra, Nilsson, Cecilia, Jakobsson, Frida, Valachis, Antonios, Papantoniou, Dimitrios, Nordin Danfors, Agneta, Johansson, Hemming, Sundin, Anders, Brandberg, Yvonne, Ullenhag, Gustav J

“…The benefit of imaging in the follow-up setting for high-risk melanoma patients is uncertain, and even less is known about the impact of intensive follow-up on…”
Get full text

ERBB2 and PTPN2 gene copy numbers as prognostic factors in HER2‑positive metastatic breast cancer treated with trastuzumab by Ellegård, Sander, Veenstra, Cynthia, Pérez-Tenorio, Gizeh, Fagerström, Victor, Gårsjö, Jon, Gert, Krista, Sundquist, Marie, Malmström, Annika, Wingren, Sten, Elander, Nils O, Hallbeck, Anna-Lotta, Stål, Olle

“…Trastuzumab has markedly improved the treatment and long-term prognosis of patients with HER2-positive breast cancer. A frequent clinical challenge in patients…”
Get full text

Mistletoe extract in patients with advanced pancreatic cancer: a double-blind, randomized, placebo-controlled trial (MISTRAL) by Wode, Kathrin, Kienle, Gunver S., Björ, Ove, Fransson, Per, Sharp, Lena, Elander, Nils O., Bernhardson, Britt-Marie, Johansson, Birgit, Ardnor, Christina Edwinsdotter, Scheibling, Ursula, Nordberg, Johanna Hök, Henriksson, Roger

“…Background: Patients with advanced pancreatic cancer have limited survival and few treatment options. We studied whether mistletoe extract (ME), in addition to…”
Get full text

Mistletoe Extract in Patients With Advanced Pancreatic Cancer: a Double-Blind, Randomized, Placebo-Controlled Tial (MISTRAL) by Wode, Kathrin, Kienle, Gunver S, Björ, Ove, Fransson, Per, Sharp, Lena, Elander, Nils O, Bernhardson, Britt-Marie, Johansson, Birgit, Edwinsdotter Ardnor, Christina, Scheibling, Ursula, Hök Nordberg, Johanna, Henriksson, Roger

“…Patients with advanced pancreatic cancer have limited survival and few treatment options. We studied whether mistletoe extract (ME), in addition to…”
Get full text

Mistletoe Extract in Patients With Advanced Pancreatic Cancer by Wode, Kathrin, Kienle, Gunver S, Björ, Ove, Fransson, Per, Sharp, Lena, Elander, Nils O, Bernhardson, Britt-Marie, Johansson, Birgit, Edwinsdotter Ardnor, Christina, Scheibling, Ursula, Hök Nordberg, Johanna, Henriksson, Roger

“…Patients with advanced pancreatic cancer have limited survival and few treatment options. We studied whether mistletoe extract (ME), in addition to…”
Get full text